Search
Now showing items 1-2 of 2
Identification of long non-coding RNAs overcoming tamoxifen resistance in estrogen receptor alpha positive breast cancer
(Bilkent University, 2017-09)
Most of the breast cancer incidences all over the world fall into Estrogen Receptor alpha
(ERα)-positive breast cancer subtype, which are treated with endocrine therapy. Tamoxifen, a
selective ER modulator drug, is the ...
hsa-miR-497 as a modulator of the expression in the presence or absence of chrna5 in breast cancer
(Bilkent University, 2017-06)
CHRNA5 is an important ligand-gated receptor with roles in addiction and in cancer. In
lung cancer, CHRNA5 dysregulation is well known. There is also expression of CHRNA5
in breast cancer cell lines. microRNAs regulate ...